Skip to content
Biodatica
Start free

Investigator

Sebastian Linnemayr

RAND CORPORATION · funded by NIMH, NICHD

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.3M

Summed across those awards.

First award
May 17, 2021

Latest Sep 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)

    $582k

    Sep 1, 2024NIMHRAND CORPORATIONNIH RePORTER · 11171473 (opens the source filing in a new tab)

  2. R01

    INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)

    $106k

    Sep 1, 2024NIMHRAND CORPORATIONNIH RePORTER · 11378660 (opens the source filing in a new tab)

  3. R01

    Goals for Adherence with Low-cost Incentives (GOALS)

    $574k

    May 17, 2021NICHDRAND CORPORATIONNIH RePORTER · 11036313 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources